Doctor Takahide Kadosaka

Hokkaido University, Sapporo (Japan)

Follow

Contributor content

Empagliflozin attenuates arrhythmogenesis via inhibition of O-GlcNAcylation in diastolic phase of diabetic cardiomyopathy.

Presentation

Empagliflozin attenuates arrhythmogenesis via inhibition of O-GlcNAcylation in diastolic phase of diabetic cardiomyopathy.

ESC 365 is supported by

novartis

Explore sponsored resources